Autolus Therapeutics Plc (AUTL)
1.19
-0.04
(-3.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.21
+0.02
(+1.68%)
After-Hours: 06:58
Autolus Therapeutics Market Cap : 316.94M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 316.94M |
| November 11, 2026 | 328.93M |
| November 10, 2026 | 351.57M |
| November 09, 2026 | 351.57M |
| November 06, 2026 | 340.92M |
| November 05, 2026 | 335.59M |
| November 04, 2026 | 367.30M |
| November 03, 2026 | 376.62M |
| November 02, 2026 | 377.95M |
| October 30, 2026 | 404.57M |
| October 29, 2026 | 420.54M |
| October 28, 2026 | 433.84M |
| October 27, 2026 | 412.55M |
| October 26, 2026 | 407.23M |
| October 23, 2026 | 409.89M |
| October 22, 2026 | 420.54M |
| October 21, 2026 | 431.18M |
| October 20, 2026 | 441.83M |
| October 19, 2026 | 423.20M |
| October 16, 2026 | 425.86M |
| October 15, 2026 | 457.80M |
| October 14, 2026 | 449.81M |
| October 13, 2026 | 431.18M |
| October 12, 2026 | 463.12M |
| October 09, 2026 | 481.75M |
| Date | Value |
|---|---|
| October 08, 2026 | 471.11M |
| October 07, 2026 | 481.75M |
| October 06, 2026 | 476.43M |
| October 05, 2026 | 487.08M |
| October 02, 2026 | 473.77M |
| October 01, 2026 | 492.40M |
| September 30, 2026 | 516.36M |
| September 29, 2026 | 495.06M |
| September 28, 2026 | 495.06M |
| September 25, 2026 | 493.73M |
| September 24, 2026 | 508.37M |
| September 23, 2026 | 519.02M |
| September 22, 2026 | 540.31M |
| September 21, 2026 | 516.36M |
| September 18, 2026 | 516.36M |
| September 17, 2026 | 511.03M |
| September 16, 2026 | 497.72M |
| September 15, 2026 | 503.05M |
| September 14, 2026 | 516.36M |
| September 11, 2026 | 500.39M |
| September 10, 2026 | 521.68M |
| September 09, 2026 | 540.31M |
| September 08, 2026 | 561.60M |
| September 04, 2026 | 596.20M |
| September 03, 2026 | 609.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bicycle Therapeutics Plc | 174.42M |
| Biodexa Pharmaceuticals Plc | 2.220B |
| argenx SE | 60.73B |
| NuCana Plc | 4.008M |
| Mereo BioPharma Group Plc | 48.71M |
Market Cap Related Metrics
| PS Ratio | 2.305 |
| PEG Ratio | -0.089 |
| Price to Book Value | 15.43 |
| Price | 1.19 |
| Earnings Yield | -80.80% |
| PEGY Ratio | -0.089 |